Sinco Pharmaceuticals Holdings Limited (HKG:6833)
0.1750
-0.0080 (-4.37%)
Jan 21, 2026, 3:37 PM HKT
HKG:6833 Revenue
Sinco Pharmaceuticals Holdings had revenue of 1.20B CNY in the half year ending June 30, 2025, with 9.70% growth. This brings the company's revenue in the last twelve months to 2.49B, down -16.34% year-over-year. In the year 2024, Sinco Pharmaceuticals Holdings had annual revenue of 2.82B with 11.07% growth.
Revenue (ttm)
2.49B CNY
Revenue Growth
-16.34%
P/S Ratio
0.14
Revenue / Employee
8.56M CNY
Employees
291
Market Cap
372.02M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.82B | 281.26M | 11.07% |
| Dec 31, 2023 | 2.54B | 268.56M | 11.82% |
| Dec 31, 2022 | 2.27B | 247.45M | 12.23% |
| Dec 31, 2021 | 2.02B | -25.75M | -1.26% |
| Dec 31, 2020 | 2.05B | 873.39M | 74.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sinopharm Group | 626.85B |
| Charmacy Pharmaceutical | 4.65B |
| Sipai Health Technology | 3.75B |
| IVD Medical Holding | 3.37B |
| ClouDr Group | 2.47B |
| 160 Health International | 698.59M |
| Ziyuanyuan Holdings Group | 575.61M |
| Wanjia Group Holdings | 163.70M |